Heart Failure Clinics

Article	Citations
Heart Failure with Preserved Ejection Fraction	54
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	33
Unusual Forms of Pulmonary Hypertension	27
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	26
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	26
Contents	25
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction	25
Changing Landscape of Heart Failure Imaging	22
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	21
Forthcoming Issues	21
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	20
Therapy-Related Clonal Hematopoiesis	20
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	19
When all Else Fails, Try This	19
Genetics of High-Altitude Pulmonary Edema	18
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Preload Reduction Therapies in Heart Failure	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Contributors	16
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	16
Contributors	15
Hypertension and Heart Failure with Preserved Ejection Fraction	15
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	14

Specific Therapy in Transthyretin Amyloid Cardiomyopathy	13
Heart Failure Clinics	13
Copyright	13
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction	12
Myocardial Dysfunction in Patients with Cancer	12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	12
Coronary Angiography in the Evaluation of Systolic Heart Failure	11
Arrythmia-Mediated Valvular Heart Disease	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Contributors	10
Advanced Heart Failure in a Special Population	10
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	10
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	10
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	9
Application of 3D Printing Technology in Heart Failure	9
Noncoding RNAs in Pulmonary Arterial Hypertension	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	9
Cardiac Amyloidosis	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	9
Contents	9
Cardiac Contractility Modulation	9
SGLT2 Inhibitors in Heart Failure	9
Contributors	9
Copyright	8
Inotropes in Patients with Advanced Heart Failure	8
Preface	8
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
Disease-modifier Drugs in Patients with Advanced Heart Failure	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Contents	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	7
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	7
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis	6
Copyright	6
Sleep Disorder and Heart Failure with Preserved Ejection Fraction	6
Advanced Heart Failure in Special Population	6
Contents	6
Aortic Valvular Stenosis and Heart Failure	6
Adults with Congenital Heart Disease and Transplant	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	6
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	6
SGLT2 Inhibitors and Peripheral Vascular Events	5
Clinical Practice Guidelines in Cardio-Oncology	5
Contents	5
Remote Monitoring Devices and Heart Failure	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Clinical Use of Biomarkers in Cardiac Amyloidosis	5

Forthcoming Issues	4
Latest Updates in Heart Failure Imaging	4
Novel Non-pharmacological Approaches to Heart Failure	4
Pathophysiology of Cardiac Amyloidosis	4
Coronary Microvascular Dysfunction	4
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	4
Contributors	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction	4
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	4
Contributors	4
Contributors	4
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	4
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome	3
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	3
Novel Approaches to Sleep Apnea in Heart Failure	3
Copyright	3
Contents	3
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	3
Copyright	3
Changing Landscape of Heart Failure Imaging	3
Forthcoming Issues	3
Adult Congenital Heart Disease	3
Copyright	2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies	2
Using Artificial Intelligence to Better Predict and Develop Biomarkers	2
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	2
Challenges in Pulmonary Hypertension	2
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction	2
Clinical and Molecular Aspects of Naxos Disease	2
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	2
Obesity and Heart Failure with Preserved Ejection Fraction	2
Contributors	2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	2
Contents	2
Forthcoming Issues	2
Contents	2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	2
Contributors	2
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	2
Mechanical Circulatory Support in COVID-19	2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	2
Pathophysiology of Heart Failure with Preserved Ejection Fraction	1
Contents	1
Contributors	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
How to Start an Invasive Cardiopulmonary Exercise Testing Program	1
Surgical Revascularization Decisions in Ischemia and Heart Failure	1
Multimodality Imaging in Aortic Stenosis	1
Contributors	1
Copyright	1
Left Ventricular Assist Device	1
Congestion in Patients with Advanced Heart Failure	1
Forthcoming Issues	1
Extracardiac Prothrombotic Effects of COVID-19	1
Challenges in Pulmonary Hypertension	1
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension	1
Cardiopulmonary Exercise Testing in Research	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Copyright	1
Translational Research in Cardio-Oncology	1
Use and Prognostic Implications of Cardiac Troponin in COVID-19	1
Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure	1
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Contents	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
Contributors	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Viability and Congestive Heart Failure	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
Spontaneous Coronary Artery Dissection	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0

Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care	0
The War Against Heart Failure Hospitalizations	0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Amyloidosis and Amyloidogenesis	0
Contributors	0
Covid-19	0
Forthcoming Issues	0
Targeted Therapies for Microvascular Disease	0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	0
Renoprotective Effects of SGLT2 Inhibitors	0
Stress Testing in Heart Failure with Preserved Ejection Fraction	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
Copyright	0
Forthcoming Issues	0
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease	0
Copyright	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Contributors	0
Interatrial Shunt Devices	0
Cardioprotection of High-Risk Individuals	0
Machine Learning in Cardiovascular Imaging	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Arrhythmogenic Cardiomyopathy	0
Tricuspid Regurgitation and Right Heart Failure	0
Contents	0
Artificial Intelligence and Mechanical Circulatory Support	0
Cardiovascular Health Care Implications of the COVID-19 pandemic	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
Listing Criteria for Heart Transplant	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Copyright	0
Heart Failure Preserved Ejection Fraction in Women	0
Primary Mitral Regurgitation and Heart Failure	0
Advanced Heart Failure in Special Population—Pediatric Age	0
Genetics in Congenital Heart Diseases	0
Contents	0
Forthcoming Issues	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
The Arrhythmic Phenotype in Cardiomyopathy	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
T-cell Immunotherapy and Cardiovascular Disease	0
Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction	0
Contents	0
Contents	0
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy	0
Copyright	0
Forthcoming Issues	0
Contributors	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0
Hypertrophic Cardiomyopathy in RASopathies	0
Copyright	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI	0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure	0
Oxygen Therapy in Pulmonary Vascular Disease	0
Valvular Heart Disease and Heart Failure	0
Digital Health	0
Contributors	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Forthcoming Issues	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Genotype-Phenotype Correlations in ATTR Amyloidosis	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Forthcoming Issues	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Cardiovascular Effects of COVID-19	0
Standard Therapy in Cardiac Amyloidosis	0
Cardiac Amyloidosis	0
Contents	0
Forthcoming Issues	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Mildly Elevated Pulmonary Hypertension	0
Clinical Manifestations of 22q11.2 Deletion Syndrome	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Secondary Mitral Regurgitation and Heart Failure	0
Digital Transformation in Medicine to Enhance Quality of Life, Longevity, and Health Equity	0
SGLT-2 Inhibitors	0
Pregnancy and Pulmonary Hypertension	0
Contributors	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Forthcoming Issues	0
Heart Failure with Reduced Ejection Fraction	0
Pathophysiology of Advanced Heart Failure	0
Contents	0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure	0
Contents	0
Exercise Testing in Elite Athletes	0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0
Framework for Digital Health Phenotypes in Heart Failure	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0